Naloxiphan
PubChem Notes:
Levallorphan An opioid antagonist with properties similar to those of NALOXONE; in addition it also possesses some agonist properties. It should be used cautiously; levallorphan reverses severe opioid-induced respiratory depression but may exacerbate respiratory depression such as that induced by alcohol or other non-opioid central depressants. (From Martindale, The Extra Pharmacopoeia, 30th ed, p683)
Molecular Formula:
C19H25NO
InChI: InChI=1/C19H25NO/c1-2-10-20-11-9-19-8-4-3-5-16(19)18(20)12-14-6-7-15(21)13-17(14)19/h2,6-7,13,16,18,21H,1,3-5,8-12H2/t16-,18-,19-/m0/s1
InChIKey: InChIKey=OZYUPQUCAUTOBP-WDSOQIARBF
SMILES: C=CCN1CCC23CCCCC2C1CC4=C3C=C(C=C4)O
Names:
Levallofano [DCIT]
Levallorphane [INN-French]
Levallorphanum [INN-Latin]
levallorphan
Levalorfano [INN-Spanish]
L-N-Allyl-3-hydroxymorphinan
Morphinan-3-ol, 17-allyl-
Naloxiphan
N-Allyl-3-hydroxymorphinan
17-Allylmorphinan-3-ol
Registries:
PubChem CID 5359371
PubChem ID 152219
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|